OBO ID: CHEBI:42355
Term Name: erythromycin A Search Ontology:
Synonyms:
  • (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
  • (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxa
  • 3''-O-demethylerythromycin
  • Abomacetin
  • eritromicina
  • erthromycin
  • Erythromycin
  • ERYTHROMYCIN A
  • Erythromycin C
  • erythromycine
  • erythromycinum
Definition: An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.
References:
  • Beilstein:75000
  • Beilstein:75279
  • CAS:114-07-8
  • CAS:1675-02-1
  • DrugBank:DB00199
  • Drug_Central:1048
  • KEGG:C01912
  • KEGG:D00140
  • LINCS:LSM-3416
  • LIPID_MAPS_instance:LMPK04000006
  • MetaCyc:CPD-13804
  • PDBeChem:ERY
  • Patent:US2823203
  • Reaxys:75279
Ontology: ChEBI  ( EBI )
PHENOTYPE No data available